Deborah Birx Armata Pharmaceuticals, Inc. (ARMP) insider trading activity

ARMP Quotes by TradingView

Deborah Birx is Chief Executive Officer of Armata Pharmaceuticals, Inc.. Currently has a direct ownership of 260,000 shares of ARMP, which is worth approximately $507,000. The most recent transaction as insider was on Mar 14, 2024, when has been sold 60,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K
0% 3M change
30.0% 12M change
Total Value Held $507,000

Deborah Birx Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 18.75%
260,000 Common Stock
Dec 21 2023
BUY
Grant, award, or other acquisition
-
200,000 Added 50.0%
200,000 Common Stock

Also insider at

INVA
Innoviva, Inc. Healthcare
Director
DB

Deborah Birx

Chief Executive Officer
Burlingame, CA

Track Institutional and Insider Activities on ARMP

Follow Armata Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARMP shares.

Notify only if

Insider Trading

Get notified when an Armata Pharmaceuticals, Inc. insider buys or sells ARMP shares.

Notify only if

News

Receive news related to Armata Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARMP